John T. Schiller is the deputy chief and head of the neoplastic disease section, laboratory of cellular oncology at the U.S. National Cancer Institute (NCI), and an NIH Distinguished Investigator. With Douglas R. Lowy, he made key contributions to papillomavirus virus molecular biology and the development of the HPV vaccine. Schiller was the recipient of the National Medal of Technology and Innovation in 2014[1][2] and the Lasker-DeBakey Clinical Medical Research Award in 2017.[3]
Career and Research
Schiller earned his B.S. in molecular biology from the University of Wisconsin-Madison in 1975 and his Ph.D. from the University of Washington in Seattle in 1982. He joined Douglas R. Lowy's Laboratory of Cellular Oncology as a National Research Service Award postdoctoral fellow in 1983. In 1998, he became the chief of the neoplastic disease section and was designated as an NIH Distinguished Investigator in 2016.[3] He was elected to the National Academy of Sciences in 2020.[4]
In the early 1990s, Schiller and Lowy worked on the discovery and development of a virus-like particle vaccine of the human papillomavirus. That initial work would ultimately result in the development of the HPV vaccine.[5]
Awards
References
|
|---|
| International | |
|---|
| National | |
|---|
| Academics | |
|---|
